Anja E.
- Country
- Germany
- Department
- 1604:Klinik für Augenheilkunde
Research Overview
- Evaluation of Low-Dose Atropine Sulfate Eye Drops for Myopia Progression Control in Pediatric Caucasian Patients: A Randomized, Placebo-Controlled Trial
- Phase III Randomized Double‑Masked Placebo‑Controlled Study of Subcutaneous Satralizumab in Adults with Moderate‑to‑Severe Thyroid Eye Disease
- Evaluation of Safety and Tolerability of Teprotumumab Dosing Durations in Patients with Thyroid Eye Disease: A Phase 3b/4 Randomized, Double-Masked, Multicenter Trial
Data & Insights
Has run more than one trial at 39 of 120 partner sites.
Specializations
Ophthalmic Disorders
This investigator specializes in the treatment of progressive myopia in pediatric populations, conducting research into innovative therapeutic approaches for vision correction and myopia control in children.
- Pediatric Vision Care
- Myopia Management
- Refractive Error Treatment
Their work includes evaluation of pharmacological interventions for myopia progression control.
Thyroid Eye Disease Management
The investigator has extensive experience in treating thyroid eye disease (TED), with particular focus on moderate to severe cases requiring specialized intervention.
- Advanced TED Therapeutics
- Proptosis Treatment
- Novel Biological Therapies
Their research encompasses various therapeutic approaches including intravenous and subcutaneous treatment modalities.
Clinical Immunology
The investigator focuses on immunological interventions in ophthalmology, particularly exploring biological treatments for autoimmune eye conditions.
- Biological Response Monitoring
- Immunological Therapy Assessment
- Treatment Duration Optimization
Their work includes evaluation of novel immunological agents and their efficacy in treating ocular disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.